Stability studies of isotope-specific 2-ketoglutaric acid
Ended Awarded Last action
- Contract number
- 75N91022F00001
- Awardee
-
Mriglobal UEI HKQHNFKNKL15
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $48,980
Award facts
- Contract value 100% obligated
- $48,980.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Kansas City, MO 64110, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N91022F00001?
75N91022F00001 was awarded to Mriglobal by National Cancer Institute (National Institutes of Health) on February 16, 2022.
How much is contract 75N91022F00001 worth?
The government has obligated $48,980 on 75N91022F00001.
Is contract 75N91022F00001 an order under another contract?
Yes. 75N91022F00001 is a delivery order under HHSN261201700011I, an indefinite delivery contract, on NIH Analysis of Anti-Cancer Chemicals 2017-2022.
Was contract 75N91022F00001 competed?
The extent of competition for 75N91022F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award